Results 111 to 120 of about 84,576 (334)

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo   +11 more
wiley   +1 more source

Hormone replacement therapy [PDF]

open access: yes, 2012
Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core   +2 more sources

A case of chronic thromboembolic pulmonary hypertension

open access: yesItalian Journal of Medicine, 2020
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially fatal complication of pulmonary embolism (PE). Organized thrombus in the pulmonary artery causes a chronic obstruction, leading to a vascular system remodeling, an increase of pulmonary vascular resistance and a chronic pulmonary hypertension.
Lucio Brugioni   +9 more
openaire   +4 more sources

Pulmonary Transit Time Can Be Accurately Quantified From Non‐Arterial Input Function Series in First‐Pass Cardiac Perfusion MRI

open access: yesMagnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose Previous studies suggested that arterial‐input‐function (AIF) images are necessary to avoid signal saturation for pulmonary transit time (PTT) measurements. This study challenges that notion by investigating whether PTT can be accurately measured using blood pool signals from myocardial enhancement (non‐AIF) images during resting first‐
Mingyue Zhao   +8 more
wiley   +1 more source

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

open access: yesMethodist DeBakey Cardiovascular Journal
Chronic thromboembolic pulmonary hypertension is a rare form of pulmonary hypertension in patients who have evidence of chronic thromboembolic occlusion of the pulmonary vasculature.
Lauren N. Carlozzi   +2 more
doaj   +1 more source

A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

open access: yesPLoS ONE, 2021
Balloon pulmonary angioplasty improves prognosis by alleviating pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension, even with incomplete revascularization.
Shinya Fujii   +7 more
doaj   +1 more source

Demographics and Outcomes of Pulmonary Hypertension Patients in United States Emergency Departments [PDF]

open access: yes, 2020
Introduction: Pulmonary hypertension (PH) is a common, yet under-diagnosed, contributor to morbidity and mortality. Our objective was to characterize the prevalence of PH among adult patients presenting to United States (US) emergency departments (ED ...
Camargo Jr., Carlos A.   +2 more
core  

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease [PDF]

open access: yes, 2015
International audienceBackground: Assessment of dyspnea in COPD patients relies in clinical practice on the modified Medical Research Council (mMRC) scale, whereas the Baseline Dyspnea Index (BDI) is mainly used in clinical trials. Little is known on the
Caillaud, Denis   +6 more
core   +4 more sources

Pulmonary thrombo-endarterectomy for chronic thromboembolic pulmonary artery hypertension [PDF]

open access: diamond, 2021
Sofia Martìn Suàrez   +11 more
openalex   +1 more source

Physiologically‐Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pediatric extrapolation strategies issued by health authorities have streamlined pediatric drug development and reduced the unnecessary burden of conducting pediatric clinical studies. In line with these strategies, physiologically based pharmacokinetic (PBPK) models have been utilized extensively for initial dosing regimen and sampling ...
James W. T. Yates   +26 more
wiley   +1 more source

Home - About - Disclaimer - Privacy